Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-185-5 | CAS number: 1310-73-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1 mg/m³
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
- Overall assessment factor (AF):
- 1
- Dose descriptor:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Additional information - workers
The focus is the occurence of local effects after acute and repeated exposure at those places where NaOH is produced and/or used. This is because NaOH is not expected to become systemically available in the body under normal handling and use conditions, i.e. neither the concentration of sodium in the blo The focus is the occurence of local effects after acute and repeated exposure at those places where NaOH is produced and/or used. This is because NaOH is not expected to become systemically available in the body under normal handling and use conditions, i.e. neither the concentration of sodium in the blood nor the pH of the blood will be increased (EU RAR of sodium hydroxide, 2007; section 4.1.3.1, page 73). Acute exposure Acute / short-term exposure and long-term exposure - systemic effects NaOH is not expected to become systemically available in the body under normal handling and use conditions, i.e. neither the concentration of sodium in the blood nor the pH of the blood will be increased (EU RAR of sodium hydroxide, 2007; section 4.1.3.1, page 73). Therefore, it is not useful to derive a DNEL for acute exposure, systemic effects. Acute - short-term exposure - local effects (dermal) According to the CLP Regulation No 1272/2008 Annex VI Table 3.1, the concentration limit for corrosivity of NaOH is considered to be 2%. Acute - short-term exposure - local effects (inhalation) According to chapter R8 of the ECHA "Guidance on information requirements and chemical safety assessment' a DNEL for acute toxicity should be derived if an acute toxicity hazard (leading to C&L) has been identified. Sodium hydroxide is not classified regarding acute inhalation toxicity. In addition, a DNEL for acute toxicity should be derived if there is a potential for high peak exposures, for instance when sampling or connecting/disconnecting vessels. This is not the case for sodium hydroxide. High peak exposure do not occur during the manufacturing or use. Long-term exposure Long-term exposure - local effects (dermal DNEL in mg/kg bw): No DNEL long-term exposure - local effects could be derived as no reliable dose descriptors were available for that route of exposure. Long-term exposure - local effects (inhalation DNEL in mg/m3): The most relevant starting point from the available data is the study of Fritschi et al (2001), which is a cross-sectional survey of 2404 employees from three aluminium refineries. Of these subjects, 1045 had been exposed to sodium hydroxide mist, leaving 1553 unexposed subjects. Exposure to sodium hydroxide mist had been assessed on a semi-quantitative basis and the exposed subjects had been assigned to one of three exposure groups: low (<0.05 mg/m3), medium (0.05 – 1.0 mg/m3) or high (>1.0 mg/m3) based on an assessment of peak exposures over a 15 -minute period. The authors concluded that exposure to high levels of sodium hydroxide mist (>1.0 mg/m3) was associated with an increased prevalence of reporting work-related wheeze and rhinitis, but not impairment of lung function. These symptomatic reports of respiratory tract irritation, in the lack of any measured functional change in lung performance, suggest that any effects were minimal. Such reporting is also subject to recall bias, which can lead to over-reporting of symptomatology. No increased prevalence of respiratory symptoms was reported for the subjects in the medium exposure group. This data suggests that the NOEL for respiratory irritation due to exposure to sodium hydroxide mist in a large sample of subjects from three factories was 1.0 mg/m3. This value is likely to be a conservative estimate due to the study design. As the study was conducted in human subjects, no interspecies assessment factor is required. Similarly, assessment factors to take account of differences in exposure duration, dose-response or quality of the database are not required. It is noted that in excess of 40% of the study subjects were reported to be atopic. This distribution suggests that the study population were towards the more sensitive end of the overall population in terms of their response to respiratory irritants. This fact, coupled with the fact that a relatively large random sample of workers had been studied, suggest also that no assessment factor is required to account for intraspecies differences in the human population. In addition, it is noted that in many EU countries, the OEL (8-hour TWA) for sodium hydroxide is 2.0 mg/m3, with a few exceptions (Czech Republic - 1.0 mg/m3; Poland – 0.5 mg/m3) (see Table 1). In the UK, a Workplace Exposure Limit (15-minute STEL) of 2.0 mg/m3 exists. This value is most probably based on the ACGIH TLV Ceiling Limit of 2.0 mg/m3, which itself is based on “noticeable, but not excessive, ocular and upper respiratory tract irritation” (ACGIH, 1997). This latter statement is attributed to Patty, 1947. These OEL values are broadly consistent with a NOEL in humans for respiratory irritation of 1.0 mg/m3. 1 mg/m3 is considered to be the NOEL for sodium hydroxide mist in humans for respiratory irritation For the reasons stated above, it is proposed that no assessment factors are required to derive the DNEL. As a result, the DNEL for sodium hydroxide for long-term inhalation, workers = 1.0 mg/m³. Table 25. Occupational Exposure Limits (OELs) in the EU and Norway (ACGIH, 2006) EU Member State Unit TW ST Ceiling Referenceod nor the pH of the blood will be increased (EU RAR of sodium hydroxide, 2007; section 4.1.3.1, page 73).
Acute exposure
Acute / short-term exposure and long-term exposure - systemic effects NaOH is not expected to become systemically available in the body under normal handling and use conditions, i.e. neither the concentration of sodium in the blood nor the pH of the blood will be increased (EU RAR of sodium hydroxide, 2007; section 4.1.3.1, page 73). Therefore, it is not useful to derive a DNEL for acute exposure, systemic effects.
Acute - short-term exposure - local effects (dermal)
According to the CLP Regulation No 1272/2008 Annex VI Table 3.1, the concentration limit for corrosivity of NaOH is considered to be 2%.
Acute - short-term exposure - local effects (inhalation)
According to chapter R8 of the ECHA "Guidance on information requirements and chemical safety assessment' a DNEL for acute toxicity should be derived if an acute toxicity hazard (leading to C&L) has been identified. Sodium hydroxide is not classified regarding acute inhalation toxicity. In addition, a DNEL for acute toxicity should be derived if there is a potential for high peak exposures, for instance when sampling or connecting/disconnecting vessels. This is not the case for sodium hydroxide. High peak exposure do not occur during the manufacturing or use.
Long-term exposure
Long-term exposure - local effects (dermal DNEL in mg/kg bw):
No DNEL long-term exposure - local effects could be derived as no reliable dose descriptors were available for that route of exposure.
Long-term exposure - local effects (inhalation DNEL in mg/m3):
The most relevant starting point from the available data is the study of Fritschi et al (2001), which is a cross-sectional survey of 2404 employees from three aluminium refineries. Of these subjects, 1045 had been exposed to sodium hydroxide mist, leaving 1553 unexposed subjects.
Exposure to sodium hydroxide mist had been assessed on a semi-quantitative basis and the exposed subjects had been assigned to one of three exposure groups: low (<0.05 mg/m3), medium (0.05 – 1.0 mg/m3) or high (>1.0 mg/m3) based on an assessment of peak exposures over a 15 -minute period. The authors concluded that exposure to high levels of sodium hydroxide mist (>1.0 mg/m3) was associated with an increased prevalence of reporting work-related wheeze and rhinitis, but not impairment of lung function. These symptomatic reports of respiratory tract irritation, in the lack of any measured functional change in lung performance, suggest that any effects were minimal. Such reporting is also subject to recall bias, which can lead to over-reporting of symptomatology. No increased prevalence of respiratory symptoms was reported for the subjects in the medium exposure group.
This data suggests that the NOEL for respiratory irritation due to exposure to sodium hydroxide mist in a large sample of subjects from three factories was 1.0 mg/m3. This value is likely to be a conservative estimate due to the study design.
As the study was conducted in human subjects, no interspecies assessment factor is required. Similarly, assessment factors to take account of differences in exposure duration, dose-response or quality of the database are not required. It is noted that in excess of 40% of the study subjects were reported to be atopic. This distribution suggests that the study population were towards the more sensitive end of the overall population in terms of their response to respiratory irritants. This fact, coupled with the fact that a relatively large random sample of workers had been studied, suggest also that no assessment factor is required to account for intraspecies differences in the human population.
In addition, it is noted that in many EU countries, the OEL (8-hour TWA) for sodium hydroxide is 2.0 mg/m3, with a few exceptions (Czech Republic - 1.0 mg/m3; Poland – 0.5 mg/m3) (see Table 1). In the UK, a Workplace Exposure Limit (15-minute STEL) of 2.0 mg/m3 exists. This value is most probably based on the ACGIH TLV Ceiling Limit of 2.0 mg/m3, which itself is based on “noticeable, but not excessive, ocular and upper respiratory tract irritation” (ACGIH, 1997). This latter statement is attributed to Patty, 1947. These OEL values are broadly consistent with a NOEL in humans for respiratory irritation of 1.0 mg/m3.
1 mg/m3 is considered to be the NOEL for sodium hydroxide mist in humans for respiratory irritation For the reasons stated above, it is proposed that no assessment factors are required to derive the DNEL.
As a result, the DNEL for sodium hydroxide for long-term inhalation, workers = 1.0 mg/m³.
Table 25. Occupational Exposure Limits (OELs) in the EU and Norway (ACGIH, 2006)
EU Member State |
Unit |
TW |
ST |
Ceiling |
Reference |
Austria |
mg/m3 |
2 |
4 |
|
|
Belgium |
mg/m3 |
|
|
2 |
ACGIH, 2006 |
Czech Republic |
mg/m3 |
1 |
2 |
|
ACGIH, 2006 |
Denmark |
mg/m3 |
2 |
|
|
|
Finland |
mg/m3 |
2 |
|
|
ACGIH, 2006 |
France |
mg/m3 |
2 |
|
|
|
Hungary |
mg/m3 |
2 |
2 |
|
|
Ireland |
mg/m3 |
|
2 |
|
ACGIH, 2006 |
Norway |
mg/m3 |
|
|
2 |
ACGIH, 2006 |
Poland |
mg/m3 |
0.5 |
1 |
|
ACGIH, 2006 |
Portugal |
mg/m3 |
|
2 |
|
|
Spain |
mg/m3 |
|
2 |
|
ACGIH, 2006 |
Sweden |
mg/m3 |
1 |
|
2 |
ACGIH, 2006 |
United Kingdom |
mg/m3 |
|
2 |
|
ACGIH, 2006 |
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1 mg/m³
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
- Overall assessment factor (AF):
- 1
- Dose descriptor:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Additional information - General Population
As sodium hydroxide is not expected to become systemically available in the body under normal handling and use conditions, the focus is on possible risks from acute exposure (local effects) (EU RAR of Sodium Hydroxide, 2007; section 4.1.3.2.4.1; page 77).
Acute exposure
Acute / short-term exposure and long-term exposure - systemic effects
As sodium hydroxide is not expected to become systemically available in the body under normal handling and use conditions, the focus is on possible risks from acute exposure (local effects) (EU RAR of Sodium Hydroxide, 2007; section 4.1.3.2.4.1; page 77).
Therefore, it is not useful to derive a DNEL for acute exposure, systemic effects.
Acute - short-term exposure - local effects - dermal
According to the CLP Regulation No 1272/2008 Annex VI Table 3.1, the concentration limit for corrosivity of NaOH is considered to be 2%.
Acute - short-term exposure - local effects - inhalation
According to chapter R8 of the ECHA "Guidance on information requirements and chemical safety assessment' a DNEL for acute toxicity should be derived if an acute toxicity hazard (leading to C&L) has been identified. Sodium hydroxide is not classified regarding acute dermal toxicity.
Long-term exposure
DNEL - long term exposure - local effects - dermal:
No DNEL long-term exposure - local effects could be derived as no reliable dose descriptors were available for that route of exposure.
DNEL - long term exposure - local effects - inhalation The same point of departure is relevant for deriving a DNEL for the general population, i.e. the study by Fritschi et al (2001). The following comments apply in the assessment of the need for further Assessment Factors in deriving a local DNEL for the general population. The assessment of exposure to sodium hydroxide conducted by Fritschi et al was based on peak exposures over a 15-minute period. The same assessment of duration of exposure would be relevant for both the working population and the general population, given that the effect being assessed to dereive the NOAEL is local irritation of the respiratory tract. No further modification is therefore required to the NOAEL to take account of potential differences in the duration of exposure of the general population. In the population studied by Fritschi et al, in excess of 40% of the subjects were reported to be atopic. This distribution suggests that the study population were towards the more sensitive end of the overall population in terms of their response to respiratory irritants and, as such, could be regarded as an adequate representation of the general population in terms of their response to sodium hydroxide. It is concluded, therefore, that no additional assessment factor is required to take account of further intraspecies differences in the general human population. As a result, the DNEL for sodium hydroxide for long-term inhalation, general population = 1.0 mg/m³.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.